Compare ADMS

The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.

Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Wednesday's prices. Each symbol is a hyperlink or shortcut to more information.

ADMS 3.51%

Profile NASDAQ: ADMS $150 Million Small-Cap. Show More

ADMS Profile

Market Cap 150 Million
ADMS Description

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.

Visit Website

ADMS Earnings

EPS -0.90 P/E Ratio --
Previous Thu, Aug 8, 2019
Latest Thu, Nov 7, 2019 (6 days ago) Price +25.56%

ADMS Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADMS Charts

1 Year
Oct 10, 2019
Mar 4, 2019

Symbol Price Day Ξ” YTD Ξ”
ADMS $5.60 3.51% -38.26%


Symbol Surfing

How can we make Symbol Surfing better?


©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy